Another look at Barrett's esophagus: Current thinking on screening and surveillance strategies

Postgraduate Medicine

Volumn 110, Issue 3, 2001, Pages 57-68

  Gopal, Deepak V ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; ROFECOXIB; TUMOR MARKER;

ANTIREFLUX OPERATION; BARRETT ESOPHAGUS; CANCER SCREENING; CONFERENCE PAPER; ESOPHAGOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HUMAN; INCIDENCE; PREDICTION; REMISSION; RISK FACTOR;

EID: 0034830339     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.2001.09.1018     Document Type: Conference Paper

References (22)

1. Endoscopic surveillance of Barrett's esophagus: Risk stratification and cancer risk
2. Endoscopic biopsy can detect high-grade dysplasia or early adenocarcinoma in Barrett's esophagus without grossly recognizable neoplastic lesions
3. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus
4. Unresolved issues in Barrett's esophagus in the new millennium
5. Barrett's esophagus: Age, prevalence, and extent of columnar epithelium
6. Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology
7. Risk factors for dysplasia in patients with Barrett's esophagus (BE): Results from a multicenter consortium
8. The development of dysplasia and adenocarcinoma during endoscopic surveillance of Barrett's esophagus
9. Barrett's esophagus: A new look at surveillance based on emerging estimates of cancer risk
10. Effect of segment length on risk for neoplastic progression in patients with Barrett esophagus
11. p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: A followup study
12. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus
13. Regression of Barrett's esophagus: The role of acid suppression, surgery, and ablative methods
14. Effect of antireflux operation on Barrett's mucosa
15. Histological and anatomic changes in Barrett's esophagus after antireflux surgery
16. Regression of columnar esophageal (Barrett's) epithelium after anti-reflux surgery
17. Reversal of Barrett's esophagus with acid suppression and multipolar electrocoagulation: Preliminary results
18. Restoration of the normal squamous lining in Barrett's esophagus by argon beam plasma coagulation
19. Photodynamic therapy for Barrett's esophagus: Follow-up in 100 patients
20. Barrett's oesophagus, oesophageal cancer and colon cancer: An explanation of the association and cancer chemopreventive potential of non-steroidal anti-inflammatory drugs
21. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer
22. Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas